Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveResults1h ago

Shoppers Stop Ltd

Please find attached disclosure

Shoppers Stop Ltd reported a strong Q1FY27 with a 10% YoY growth in consolidated revenue to Rs 1,536 Cr, EBITDA up 40% YoY to Rs 43 Cr, and PAT turning positive at Rs 5 Cr compared to a loss of Rs 4 Cr in Q1FY26. Department store revenue grew by 6% LFL, and customer entry grew by 3% LFL.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults1h ago

Shoppers Stop Ltd

Please find attached disclosure

Shoppers Stop Ltd reported a strong start to FY27 with a 10% YoY increase in consolidated revenue to Rs 1,536 Cr, driven by a 40% YoY increase in EBITDA to Rs 43 Cr and a PAT of Rs 5 Cr, compared to a loss of Rs 4 Cr in Q1FY26.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveResults1h ago

Shoppers Stop Limited

General Updates

Shoppers Stop Limited has reported a strong start to FY27 with a 10% YoY increase in non-GAAP consolidated revenue to Rs 1,536 Cr, a 40% YoY increase in EBITDA to Rs 43 Cr, and a PAT of Rs 5 Cr, compared to a loss of Rs 4 Cr in Q1FY26. The company's premium portfolio contribution increased to 72%, with a 15% YoY growth in sales. The company also reported a 6% LFL growth in department store revenue, a 15% YoY growth in beauty segment sales, and a 21% YoY growth in INTUNE sales.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults1h ago

Shoppers Stop Limited

Investor Presentation

Shoppers Stop Limited has informed the Exchange about Investor Presentation, reporting strong growth on revenue and profitability, a testament to its premiumization strategy. Consolidated Revenue Rs 1,536 Cr +10% YoY and EBITDA Rs 43 Cr +40% YoY. PAT Rs 5 Cr Vs a loss of Rs 4 Cr in LY (Non GAAP).

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults1h ago

Shoppers Stop Limited

Press Release

Shoppers Stop Limited has reported a strong start to FY27 with its Non GAAP Consolidated revenue up 10% YoY to Rs 1,536 Cr; EBITDA up 40% YoY and PAT turning positive at Rs 5 Cr as compared to a loss of Rs 4 Cr in Q1FY26.

Read more →📎 1 attachment
BSEOthers▲ PositiveResults1h ago

B-Right Realestate Ltd

Pursuant to Regulation 34(1) of SEBI LODR, 2015, we are enclosing herewith Annual Report of B-Right Realestate Limited for the Financial Year 2025-26.

B-Right Realestate Ltd has released its Annual Report for FY 2025-26, highlighting a transformative year with strong growth, resilience, and operational excellence. The company achieved notable growth, strengthened its market position, and laid a solid foundation for future expansion. The report showcases robust financial results, with revenue growing by 62% to ₹169.9 crore and net profit surging to ₹35.1 crore.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults2h ago

Vardhman Special Steels Limited

Press Release

Vardhman Special Steels Limited has announced its unaudited financial results for the first quarter of the financial year 2026-27, with revenue from operations at Rs. 486.01 crore, EBITDA at Rs. 68.29 crore, and PAT at Rs. 41.19 crore.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults2h ago

Menon Bearings Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Menon Bearings Limited has informed the Exchange about the transcript of the earnings conference call for Q1 FY27. The company has recorded highest-ever sales, EBITDA, profit before tax, and PAT in the history of the company for this quarter. Despite a dynamic business environment, the company delivered robust growth in revenue and profitability, supported by healthy demand across all business segments, improved operational efficiencies, and continued focus on cost optimization and customer satisfaction.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2h ago

Dr Reddys Laboratories Ltd

Copy of Investor Presentation

Dr. Reddy's Laboratories Ltd. has announced its unaudited financial results for Q1 FY27, with a healthy double-digit base business growth and an EBITDA margin of 15.4% before the semaglutide-related impact. The company has also made significant progress across its strategic priorities, including the launch of new products and partnerships.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults2h ago

IndusInd Bank Limited

Press Release

IndusInd Bank Limited has announced its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, with net interest income at ₹4,685 crores, net profit at ₹1,037 crores, and a total capital adequacy ratio of 17.15%.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults2h ago

IndusInd Bank Limited

Investor Presentation

IndusInd Bank has released its Q1FY27 investor presentation, highlighting a 3% YoY growth in total deposits, 1% YoY growth in total loans, and a 72% YoY growth in net profit. The bank's retail deposit share increased to 49.5% from 47.9% QoQ, while wholesale loans grew 7% QoQ. Net interest margins (excluding one-offs) stood at 3.35% vs 3.46% YoY and 3.39% QoQ. The bank's asset quality continued to improve with lower slippages and NNPAs.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2h ago

Indusind Bank Ltd

Press Release : Q1 FY 26-27

Indusind Bank Ltd has announced its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, with net interest income at ₹4,685 crores, net profit at ₹1,037 crores, and a net worth of ₹64,798 crores.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2h ago

Indusind Bank Ltd

Please find attached Investor Presentation for quarter June 30, 2026

IndusInd Bank Ltd has released its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, showing a 1% YoY increase in net interest income and an 8% YoY growth in operating profit. The bank's net profit grew 72% YoY and 75% QoQ to ₹1,037crs. The bank's asset quality continued to improve with GNPA at 3.25% and NPA at 0.95%. The bank's CRAR stood at 17.15% and PCR at 71%. The bank's key financial metrics showed a 3% YoY increase in loans and a 4% QoQ increase in deposits.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2h ago

Jio Financial Services Ltd

Transcript of Presentation on the unaudited financial results (Consolidated and Standalone) for the quarter ended June 30, 2026

Jio Financial Services Ltd reported strong Q1 FY27 earnings, with Consolidated Total Income growing 141% YoY to ₹1,496 crores, and Profit Before Tax excluding dividend and exceptional item expanding 18% YoY to ₹461 crores. The company's lending business, Jio Credit, saw its Gross AUM surge 2.6x year-on-year to ₹30,667 crores, while Jio Payments Bank deposits grew 1.7x to ₹617 crores. The company's insurance premiums facilitated reached ₹238 crores, and JioBlackRock AMC scaled its closing AUM to ₹18,412 crores.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults2h ago

Dr Reddys Laboratories Ltd

Outcome of Board Meeting held on July 22, 2026

Dr Reddy's Laboratories Ltd announced unaudited financial results for the quarter ended June 30, 2026, with revenues of Rs 80,705 million, gross profit of Rs 37,540 million, and profit for the period of Rs 4,348 million. The company also announced the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, and the appointment of M/s Deloitte Haskins & Sells, LLP as Independent Registered Public Accounting Firm.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2h ago

Piramal Finance Ltd

Transcript of conference call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026

Piramal Finance Ltd reported Q1 FY2027 earnings, with growth AUM increasing by 32% YoY and total AUM growing by 25% YoY to Rs. 1,06,940 crores. PAT was up 67% YoY to Rs. 461 crores, with underlying Growth business PBT of Rs. 470 crores. The company approved a fund-raise of up to Rs. 4,000 crores.

Read more →📎 1 attachment